Shakti Pumps (India) Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 22, 2025, 9:44 am

Competitors of Shakti Pumps (India) Ltd

All Competitor Stocks of Shakti Pumps (India) Ltd

Quarterly Result

Last Updated: August 20, 2025, 3:55 am

Below is a detailed analysis of the quarterly data for Shakti Pumps (India) Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 622.00 Cr.. The value appears to be declining and may need further review. It has decreased from 665.00 Cr. (Mar 2025) to 622.00 Cr., marking a decrease of 43.00 Cr..
• For Expenses, as of Jun 2025, the value is 479.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 501.00 Cr. (Mar 2025) to 479.00 Cr., marking a decrease of 22.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 144.00 Cr.. The value appears to be declining and may need further review. It has decreased from 164.00 Cr. (Mar 2025) to 144.00 Cr., marking a decrease of 20.00 Cr..
• For OPM %, as of Jun 2025, the value is 23.00%. The value appears to be declining and may need further review. It has decreased from 25.00% (Mar 2025) to 23.00%, marking a decrease of 2.00%.
• For Other Income, as of Jun 2025, the value is 2.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4.00 Cr. (Mar 2025) to 2.00 Cr., marking a decrease of 2.00 Cr..
• For Interest, as of Jun 2025, the value is 10.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 13.00 Cr. (Mar 2025) to 10.00 Cr., marking a decrease of 3.00 Cr..
• For Depreciation, as of Jun 2025, the value is 6.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5.00 Cr. (Mar 2025) to 6.00 Cr., marking an increase of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 130.00 Cr.. The value appears to be declining and may need further review. It has decreased from 150.00 Cr. (Mar 2025) to 130.00 Cr., marking a decrease of 20.00 Cr..
• For Tax %, as of Jun 2025, the value is 25.00%. The value appears to be improving (decreasing) as expected. It has decreased from 27.00% (Mar 2025) to 25.00%, marking a decrease of 2.00%.
• For Net Profit, as of Jun 2025, the value is 97.00 Cr.. The value appears to be declining and may need further review. It has decreased from 110.00 Cr. (Mar 2025) to 97.00 Cr., marking a decrease of 13.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 8.06. The value appears to be declining and may need further review. It has decreased from 9.17 (Mar 2025) to 8.06, marking a decrease of 1.11.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 4:29 am

Growth

Last Updated: September 5, 2025, 1:26 pm

Balance Sheet

Last Updated: November 9, 2025, 2:54 pm

Below is a detailed analysis of the balance sheet data for Shakti Pumps (India) Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 123.00 Cr.. The value appears strong and on an upward trend. It has increased from 120.00 Cr. (Mar 2025) to 123.00 Cr., marking an increase of 3.00 Cr..
• For Reserves, as of Sep 2025, the value is 1,504.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,041.00 Cr. (Mar 2025) to 1,504.00 Cr., marking an increase of 463.00 Cr..
• For Borrowings, as of Sep 2025, the value is 617.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 170.00 Cr. (Mar 2025) to 617.00 Cr., marking an increase of 447.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 754.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 642.00 Cr. (Mar 2025) to 754.00 Cr., marking an increase of 112.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 2,997.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,973.00 Cr. (Mar 2025) to 2,997.00 Cr., marking an increase of 1,024.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 274.00 Cr.. The value appears strong and on an upward trend. It has increased from 227.00 Cr. (Mar 2025) to 274.00 Cr., marking an increase of 47.00 Cr..
• For CWIP, as of Sep 2025, the value is 2.00 Cr.. The value appears to be declining and may need further review. It has decreased from 33.00 Cr. (Mar 2025) to 2.00 Cr., marking a decrease of 31.00 Cr..
• For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Other Assets, as of Sep 2025, the value is 2,720.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,714.00 Cr. (Mar 2025) to 2,720.00 Cr., marking an increase of 1,006.00 Cr..
• For Total Assets, as of Sep 2025, the value is 2,997.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,973.00 Cr. (Mar 2025) to 2,997.00 Cr., marking an increase of 1,024.00 Cr..

Notably, the Reserves (1,504.00 Cr.) exceed the Borrowings (617.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Shakti Pumps (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 33.97. This value is within the healthy range. It has decreased from 76.91 (Mar 24) to 33.97, marking a decrease of 42.94.
• For Diluted EPS (Rs.), as of Mar 25, the value is 33.97. This value is within the healthy range. It has decreased from 76.91 (Mar 24) to 33.97, marking a decrease of 42.94.
• For Cash EPS (Rs.), as of Mar 25, the value is 35.63. This value is within the healthy range. It has decreased from 80.23 (Mar 24) to 35.63, marking a decrease of 44.60.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 96.59. It has decreased from 377.19 (Mar 24) to 96.59, marking a decrease of 280.60.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 96.59. It has decreased from 377.19 (Mar 24) to 96.59, marking a decrease of 280.60.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 209.32. It has decreased from 684.17 (Mar 24) to 209.32, marking a decrease of 474.85.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 51.58. This value is within the healthy range. It has decreased from 114.00 (Mar 24) to 51.58, marking a decrease of 62.42.
• For PBIT / Share (Rs.), as of Mar 25, the value is 49.92. This value is within the healthy range. It has decreased from 104.50 (Mar 24) to 49.92, marking a decrease of 54.58.
• For PBT / Share (Rs.), as of Mar 25, the value is 46.23. This value is within the healthy range. It has decreased from 94.78 (Mar 24) to 46.23, marking a decrease of 48.55.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 33.97. This value is within the healthy range. It has decreased from 70.73 (Mar 24) to 33.97, marking a decrease of 36.76.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 33.97. This value is within the healthy range. It has decreased from 70.73 (Mar 24) to 33.97, marking a decrease of 36.76.
• For PBDIT Margin (%), as of Mar 25, the value is 24.64. This value is within the healthy range. It has increased from 16.66 (Mar 24) to 24.64, marking an increase of 7.98.
• For PBIT Margin (%), as of Mar 25, the value is 23.84. This value exceeds the healthy maximum of 20. It has increased from 15.27 (Mar 24) to 23.84, marking an increase of 8.57.
• For PBT Margin (%), as of Mar 25, the value is 22.08. This value is within the healthy range. It has increased from 13.85 (Mar 24) to 22.08, marking an increase of 8.23.
• For Net Profit Margin (%), as of Mar 25, the value is 16.22. This value exceeds the healthy maximum of 10. It has increased from 10.33 (Mar 24) to 16.22, marking an increase of 5.89.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 16.22. This value is within the healthy range. It has increased from 10.33 (Mar 24) to 16.22, marking an increase of 5.89.
• For Return on Networth / Equity (%), as of Mar 25, the value is 35.16. This value is within the healthy range. It has increased from 18.75 (Mar 24) to 35.16, marking an increase of 16.41.
• For Return on Capital Employeed (%), as of Mar 25, the value is 48.39. This value is within the healthy range. It has increased from 27.35 (Mar 24) to 48.39, marking an increase of 21.04.
• For Return On Assets (%), as of Mar 25, the value is 20.68. This value is within the healthy range. It has increased from 9.77 (Mar 24) to 20.68, marking an increase of 10.91.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.03. This value is below the healthy minimum of 0.2. It has increased from 0.00 (Mar 24) to 0.03, marking an increase of 0.03.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.14. This value is within the healthy range. It has increased from 0.10 (Mar 24) to 0.14, marking an increase of 0.04.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.47. It has increased from 1.26 (Mar 24) to 1.47, marking an increase of 0.21.
• For Current Ratio (X), as of Mar 25, the value is 2.27. This value is within the healthy range. It has increased from 1.82 (Mar 24) to 2.27, marking an increase of 0.45.
• For Quick Ratio (X), as of Mar 25, the value is 1.80. This value is within the healthy range. It has increased from 1.38 (Mar 24) to 1.80, marking an increase of 0.42.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.89. This value is within the healthy range. It has increased from 3.90 (Mar 24) to 4.89, marking an increase of 0.99.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 2.59 (Mar 24) to 0.00, marking a decrease of 2.59.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 2.28 (Mar 24) to 0.00, marking a decrease of 2.28.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 97.41 (Mar 24) to 0.00, marking a decrease of 97.41.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 97.72 (Mar 24) to 0.00, marking a decrease of 97.72.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 14.01. This value is within the healthy range. It has increased from 11.73 (Mar 24) to 14.01, marking an increase of 2.28.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 10.23. This value is within the healthy range. It has increased from 8.28 (Mar 24) to 10.23, marking an increase of 1.95.
• For Enterprise Value (Cr.), as of Mar 25, the value is 11,773.51. It has increased from 2,555.39 (Mar 24) to 11,773.51, marking an increase of 9,218.12.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.68. This value exceeds the healthy maximum of 3. It has increased from 1.86 (Mar 24) to 4.68, marking an increase of 2.82.
• For EV / EBITDA (X), as of Mar 25, the value is 18.99. This value exceeds the healthy maximum of 15. It has increased from 11.19 (Mar 24) to 18.99, marking an increase of 7.80.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.68. This value exceeds the healthy maximum of 3. It has increased from 1.95 (Mar 24) to 4.68, marking an increase of 2.73.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 97.40 (Mar 24) to 0.00, marking a decrease of 97.40.
• For Price / BV (X), as of Mar 25, the value is 10.14. This value exceeds the healthy maximum of 3. It has increased from 3.54 (Mar 24) to 10.14, marking an increase of 6.60.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.68. This value exceeds the healthy maximum of 3. It has increased from 1.95 (Mar 24) to 4.68, marking an increase of 2.73.
• For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.05 (Mar 24) to 0.03, marking a decrease of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness